BamSEC and AlphaSense Join Forces
Learn More

VYNE Therapeutics Inc.

NASDAQ: VYNE    
Share price (1/8/25): $3.92    
Market cap (1/8/25): $57.8 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.6
from S-8 9 pages VYNE Therapeutics Inc. Restricted Share Unit Grant Notice
12/34/56
EX-4.5
from S-8 11 pages VYNE Therapeutics Inc. Share Option Grant Notice
12/34/56
EX-4.4
from S-8 20 pages VYNE Therapeutics Inc. 2024 Inducement Plan
12/34/56
EX-4.1
from 8-K 12 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 10-K 5 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.12
from 10-K 5 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 10-K 5 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 10-Q 27 pages Second Amended and Restated Warrant Certificate
12/34/56
EX-4.1
from 10-Q 27 pages Second Amended and Restated Warrant Certificate
12/34/56
EX-4.1
from 8-K 29 pages Form of Amended and Restated Warrant Certificate
12/34/56
EX-4.4
from 10-K 4 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from S-4/A 25 pages Amended and Restated Warrant Certificate
12/34/56
EX-4.4
from S-3 52 pages Menlo Therapeutics Inc. Indenture Dated as of , 20 [ ] Trustee
12/34/56
EX-4.2
from S-1/A 2 pages Please Insert Social Security or Other Identifying Number of Assignee
12/34/56
EX-4.3
from S-1 35 pages Menlo Therapeutics Inc. Second Amended and Restated Investors’ Rights Agreement
12/34/56
EX-4.3
from DRS 35 pages Menlo Therapeutics Inc. Second Amended and Restated Investors’ Rights Agreement
12/34/56